Kim, S. C., Neogi, T., Kim, E., Lii, J., & Desai, R. J. (2021). Trends in Utilization of Urate-Lowering Therapies Following the FDA’s Boxed Warning to Febuxostat in the U.S. Arthritis Rheumatol.
Chicago Stili AlıntıKim, Seoyoung C., Tuhina Neogi, Erin Kim, Joyce Lii, ve Rishi J. Desai. "Trends in Utilization of Urate-Lowering Therapies Following the FDA’s Boxed Warning to Febuxostat in the U.S." Arthritis Rheumatol 2021.
MLA AlıntıKim, Seoyoung C., et al. "Trends in Utilization of Urate-Lowering Therapies Following the FDA’s Boxed Warning to Febuxostat in the U.S." Arthritis Rheumatol 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..